EWTX - Edgewise Therapeutics stock rises after it prices its 21.8M offering January, 19 2024 09:00 AM Edgewise Therapeutics Inc. 2024-01-19 09:00:02 ET More on Edgewise Therapeutics Edgewise: DMD Data In The First Half Of 2024 Could Lead To Additional Testing Edgewise wins FDA orphan drug status for muscle disorder therapy For further details see: Edgewise Therapeutics stock rises after it prices its 21.8M offering